These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5545123)

  • 41. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
    Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
    J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats.
    Fischetti F; Durigutto P; Macor P; Marzari R; Carretta R; Tedesco F
    Arthritis Rheum; 2007 Apr; 56(4):1187-97. PubMed ID: 17393439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement activation by nylon- and polypropylene-looped prosthetic intraocular lenses.
    Tuberville AW; Galin MA; Perez HD; Banda D; Ong R; Goldstein IM
    Invest Ophthalmol Vis Sci; 1982 Jun; 22(6):727-33. PubMed ID: 7076418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.
    Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J
    Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complement activation products and factors influencing phagocyte migration in synovial fluids from children with chronic arthritis.
    Miller JJ; Olds LC; Huene DB
    Clin Exp Rheumatol; 1986; 4(1):53-6. PubMed ID: 3486076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitation of complement proteins in rheumatic disease.
    George D; Glass D
    Clin Rheum Dis; 1983 Apr; 9(1):177-98. PubMed ID: 6603322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
    Stojan B
    Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.
    Koch AE; Harlow LA; Haines GK; Amento EP; Unemori EN; Wong WL; Pope RM; Ferrara N
    J Immunol; 1994 Apr; 152(8):4149-56. PubMed ID: 7511670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
    Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever.
    Matzner Y; Brzezinski A
    N Engl J Med; 1984 Aug; 311(5):287-90. PubMed ID: 6738641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of immune complexes in synovial effusions of patients with rheumatoid arthritis.
    Male D; Roitt IM; Hay FC
    Clin Exp Immunol; 1980 Feb; 39(2):297-306. PubMed ID: 7389202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseases.
    March RE; Reeback JS; Holborow EJ; Jones VE; Jacoby RK
    Clin Exp Immunol; 1982 Jun; 48(3):555-60. PubMed ID: 6981473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.
    Nouri AM; Panayi GS; Goodman SM
    Clin Exp Immunol; 1984 Feb; 55(2):295-302. PubMed ID: 6607791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Activated C3 in the synovial fluid of patients with rheumatoid arthritis and arthrosis (correlations with C3, C4 and C3 proactivator/modification caused by storage)].
    Hasler F; Stojan B
    Z Rheumatol; 1981; 40(1):40-3. PubMed ID: 6908792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The demonstration of an interleukin-2 like activity in the synovial fluids of rheumatoid arthritis patients.
    Wilkins JA; Warrington RJ; Sigurdson SL; Rutherford WJ
    J Rheumatol; 1983 Feb; 10(1):109-13. PubMed ID: 6601708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification and functional assessment of C3a, C4a and C5a of the common carp (Cyprinus carpio) complement.
    Kato Y; Nakao M; Shimizu M; Wariishi H; Yano T
    Dev Comp Immunol; 2004 Jul; 28(9):901-10. PubMed ID: 15183031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD13/aminopeptidase N-induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis.
    Shimizu T; Tani K; Hase K; Ogawa H; Huang L; Shinomiya F; Sone S
    Arthritis Rheum; 2002 Sep; 46(9):2330-8. PubMed ID: 12355480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus].
    Peltier AP; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.